Evidence map›Paper›PMID 21313927›Full record

Trial reportThe journal of extra-corporeal technology2010

Using biomarkers to improve the preoperative prediction of death in coronary artery bypass graft patients.

Jeremiah R Brown, Todd A MacKenzie, Lawrence J Dacey, Bruce J Leavitt, John H Braxton, Benjamin M Westbrook, Robert E Helm, John D Klemperer, Carmine Frumiento, Gerald L Sardella and 3 more

Abstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in The journal of extra-corporeal technology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Coronary Artery Bypass Grafting: A Review of Short- and Long-Term Outcomes.The International journal of angiology : official publication of the International College of Angiology, Inc · 2025
    Review
  3. Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. sST2 as a novel biomarker for the prediction of in-hospital mortality after coronary artery bypass grafting.Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals · 2019
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Jeremiah R BrownThe Dartmouth Institute for Health Policy and Clinical Practice, Dartmouth College and Dartmouth Medical School, Lebanon, New Hampshire 03756, USA. jbrown@dartmouth.edu
Todd A MacKenzie
Lawrence J Dacey
Bruce J Leavitt
John H Braxton
Benjamin M Westbrook
Robert E Helm
John D Klemperer
Carmine Frumiento
Gerald L Sardella
Cathy S Ross
Gerald T O'Connor
Northern New England Cardiovascular Disease Study Group
Dartmouth Institute for Health Policy and Clinical Practice · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The current risk prediction models for mortality following coronary artery bypass graft (CABG) surgery have been developed on patient and disease characteristics alone. Improvements to these models potentially may be made through the analysis of biomarkers of unmeasured risk. We hypothesize that preoperative biomarkers reflecting myocardial damage, inflammation, and metabolic dysfunction are associated with an increased risk of mortality following CABG surgery and the use of biomarkers associated with these injuries will improve the Northern New England (NNE) CABG mortality risk prediction model. We prospectively followed 1731 isolated CABG patients with preoperative blood collection at eight medical centers in Northern New England for a nested case-control study from 2003-2007. Preoperative blood samples were drawn at the center and then stored at a central facility. Frozen serum was analyzed at a central laboratory on an Elecsys 2010, at the same time for Cardiac Troponin T, N-Terminal pro-Brain Natriuretic Peptide, high sensitivity C-Reactive Protein, and blood glucose. We compared the strength of the prediction model for mortality using multivariable logistic regression, goodness of fit and tested the equality of the receiving operating characteristic curve (ROC) area. There were 33 cases (dead at discharge) and 66 randomly matched controls (alive at discharge).The ROC for the preoperative mortality model was improved from .83 (95% confidence interval: .74-.92) to .87 (95% confidence interval: .80-.94) with biomarkers (p-value for equality of ROC areas .09). The addition of biomarkers to the NNE preoperative risk prediction model did not significantly improve the prediction of mortality over patient and disease characteristics alone. The added measurement of multiple biomarkers outside of preoperative risk factors may be an unnecessary use of health care resources with little added benefit for predicting in-hospital mortality.

Indexed as

Proportional Hazards ModelsAdultAgedAged, 80 and overBiomarkersCoronary Artery BypassFemaleHumansMaleMiddle AgedNew EnglandOutcome Assessment, Health CarePreoperative CarePrevalencePrognosisReproducibility of ResultsBiomarkers

Identifiers

PMID21313927
PMCPMC4680018
OpenAlexW2411975977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.